focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.20
Bid: 3.10
Ask: 3.30
Change: -0.80 (-20.00%)
Spread: 0.20 (6.452%)
Open: 4.15
High: 4.35
Low: 3.15
Prev. Close: 4.00
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EXECUTIVE CHANGE SUMMARY: Immedia Picks COO Penney As Interim CEO

Fri, 01st May 2020 14:57

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Immedia Group PLC - multi-media content - Chief Operating Officer Ross Penney named interim chief executive, with immediate effect. Bruno Brookes steps down as CEO "to focus on his other interests". Penney joined Immedia in 2006 as part of its acquisition of Cube Music.

----------

Orosur Mining Inc - South American-focused gold developer - hires Brad George as non-executive director. George is a Perth, Australia-based geoscientist with experience in South America and West Africa.

----------

ValiRx PLC - clinical stage biotechnology - Plans to appoint Suzanne Dilly as a director. Dilly has been chief executive officer of subsidiary ValiSeek Ltd since 2014.

----------

Horizon Discovery Group PLC - gene editing and modulation - Hires Siddhartha Kadia as non-executive director, replacing Susan Galbraith, effective Thursday. Kadia was CEO of EAG Laboratories until its acquisition by Eurofins Scientific in 2017. Galbraith currently is head of Early Oncology at AstraZeneca PLC, leaving Horizon Discovery due to increased responsibilities there, Horizon said.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
15 Feb 2021 11:05

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics

Read more
19 Jan 2021 16:53

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer

Read more
10 Nov 2020 17:40

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter

Read more
23 Sep 2020 19:09

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges

Read more
7 Sep 2020 11:55

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

ValiRx Loss Narrows In First Half Amid Reduction In Expenses

Read more
24 Jul 2020 17:23

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

IN BRIEF: ValiRx Raises GBP300,700 From Broker Option

Read more
23 Jul 2020 18:02

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

UK TRADING UPDATE SUMMARY: Gear4music Strikes Right Note As Sales Jump

Read more
16 Jul 2020 15:57

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Jul 2020 18:19

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

IN BRIEF: ValiRx Outlines Oncology, Women's Health Focus

Read more
6 Jul 2020 09:31

ValiRx looks to build on portfolio of drug candidates

(Sharecast News) - Medicines developer ValiRx said on Monday that it was looking to build on its existing portfolio of drug candidates and grow a pipeline of innovative, early-stage projects in the areas of oncology and women's health.

Read more
1 Jul 2020 13:10

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

IN BRIEF: ValiRx Annual Loss Narrows As Expenses Fall

Read more
16 Jun 2020 13:58

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

IN BRIEF: ValiRx Cuts Pay By Two Thirds; Terminates GeneICE Agreement

Read more
8 Jun 2020 15:39

ValiRx Delays Annual Results Amid Covid-19 Pandemic

ValiRx Delays Annual Results Amid Covid-19 Pandemic

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
2 Jun 2020 12:03

ValiRx enters collaboration agreement for Covid-19 treatment

(Sharecast News) - Biotechnology oncology company ValiRx has entered into a collaboration agreement with Oncolytika and Black Cat Bio to explore the use of VAL201 in a combination treatment for patients suffering a hyperimmune response to Covid-19.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.